Black­stone re­con­sid­ers fu­ture of Japan­ese phar­ma — re­port

Black­stone is re­port­ed­ly pon­der­ing the fu­ture of Ayu­mi Phar­ma­ceu­ti­cal, the Japan­ese phar­ma com­pa­ny it struck a deal to ac­quire three years ago.

Un­named sources …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.